An Intestinal Barrier to Obesity and Diabetes
August 4, 2014 — Another study of the safety and effectiveness of an intestinal barrier for treating obesity and type 2 diabetes provides further perspective on the potential usefulness of this device. The device, sold as the EndoBarrier® in Europe, has been available there since 2010. In the U.S., it has not yet been submitted to FDA for approval […]